Skip to content

A prospective multicenter randomized controlled trial for effect of gastric lavage on coffee ground emesis in neonates.

A prospective multicenter randomized controlled trial for effect of gastric lavage on coffee ground emesis in neonates. - A trial for effect of gastric lavage on coffee ground emesis in neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026483
Enrollment
80
Registered
2017-05-01
Start date
2018-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coffee ground emesis in neonates

Interventions

Gastric lavage with warm physiologic saline No intervention

Sponsors

Nagoya University Graduate School of Medicine Department of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Neonates who are admitted for repeating coffee ground emesis at 0days or 1day old. Gestiational age:37weeks and 0day - 41weeks and 6days Birth weight:2500-4000g General conditions and vital signs are atable

Exclusion criteria

Exclusion criteria: Patients diagnosed with disease which needs surgical therapy (e.g. intestinal malrotation) or sustained bleeding, patients requiring for another therapy for asphyxia, infection, respiratory impairment or others, patients suspicious for another disease related to poor sucking or vomiting (e.g. 21 trisomy), or patients whose parents do not agree to participate in this study are excluded.

Design outcomes

Primary

MeasureTime frame
The ratio of neonates who show feeding intolerance within 24 hours from start of feeding

Secondary

MeasureTime frame
Body weight gain until 5th day after birth and babys checkup at one month total amount of gastric residues within 24 hours from start of feeding peak value of total bilirubin

Countries

Japan

Contacts

Public ContactTakashi Maeda

Ogaki city hospital Department of Pediatrics

takashimaeda19831228@gmail.com+81-(0)584-81-3341

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026